Medicine & Life Sciences
Histone Deacetylase Inhibitors
100%
Neoplasms
77%
Histone Deacetylases
58%
Apoptosis
49%
Mucocutaneous Lymph Node Syndrome
47%
Inhibitory Concentration 50
47%
Growth
41%
Glioblastoma
40%
Taiwan
40%
Colorectal Neoplasms
39%
In Vitro Techniques
37%
Antineoplastic Agents
36%
Proteins
35%
Tubulin
35%
Therapeutics
31%
Tubulin Modulators
31%
Pharmaceutical Preparations
30%
Phosphorylation
29%
Genes
29%
Microtubules
28%
Non-Small Cell Lung Carcinoma
27%
denbinobin
27%
osthol
27%
Autophagy
26%
Down-Regulation
26%
Breast Neoplasms
26%
Population
26%
Heterografts
26%
Cell Line
25%
Temozolomide
24%
Lung Neoplasms
24%
Cell Movement
24%
Cell Death
23%
hispidulin
22%
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
22%
Gene Expression
21%
Hydroxamic Acids
21%
Single Nucleotide Polymorphism
21%
Histone Deacetylase 6
20%
Acetylation
19%
Aryl Hydrocarbon Receptors
19%
indoline
19%
Reactive Oxygen Species
18%
Neoplasm Metastasis
18%
Intravenous Immunoglobulins
18%
Vorinostat
18%
Cell Proliferation
17%
Hypoxia-Inducible Factor 1
17%
Stromal Interaction Molecule 1
17%
Triple Negative Breast Neoplasms
17%
Glioma
17%
HSP90 Heat-Shock Proteins
16%
Nanoparticles
16%
Cyclooxygenase 2
16%
Phosphotransferases
16%
Up-Regulation
15%
Ankylosing Spondylitis
15%
3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
15%
Human Umbilical Vein Endothelial Cells
14%
Histones
14%
Messenger RNA
14%
Western Blotting
14%
Protein Isoforms
14%
quinoline
14%
Pharmaceutical Chemistry
13%
Calcium
13%
Antimitotic Agents
13%
2,3,7,7a-tetrahydro-3-hydroxy-7-methyl-2-(prop-1-en-1-yl)-5H-furo(3,4-b)pyran-5-one
13%
A549 Cells
13%
MPT0B098
13%
MPT0L145
13%
DNA Damage
13%
Antibodies
13%
WMJ-S-001
12%
Phosphatidylinositol 3-Kinases
12%
Pancreatic Neoplasms
12%
Lipopolysaccharides
12%
Cisplatin
12%
fosbretabulin
12%
Polymerization
12%
Prostatic Neoplasms
12%
Binding Sites
12%
Cohort Studies
12%
Anti-Inflammatory Agents
12%
Acute Myeloid Leukemia
12%
Benzamides
12%
Genetic Polymorphisms
11%
Transforming Growth Factors
11%
Caspase 3
11%
shikonin
11%
ErbB Receptors
11%
Cell Survival
11%
Pharmacology
11%
Human Activities
11%
Osteoporosis
11%
Coronary Vessels
11%
Cell Cycle
11%
Vascular Endothelial Growth Factor A
11%
Colchicine
11%
Chemical Compounds
Histone
69%
Protein
51%
Antiproliferative
37%
Drug
35%
Antineoplastic Agent
29%
Hydroxamic Acid
25%
Antitumor
22%
Genetic Polymorphism
21%
Apoptotic
19%
Reactive Oxygen Metabolite
18%
Cell Death
16%
Resistance
15%
Retinal
15%
Osthole
14%
Temozolomide
14%
50 Percent Growth Inhibition
14%
Polymerization Reaction
14%
Colchicine
13%
Metabolite
13%
Hispidulin
12%
Acetylation
11%
Bioavailability
11%
Genotoxicity
11%
Western Blotting
10%
Structure-Activity Relationship
10%
Pharmacokinetics
10%
Bioactivity
9%
Retinal Pigment
9%
Nanocarrier
9%
Dose
9%
Antioxidant Agent
9%
Disorder
9%
Growth Inhibition
9%
Vascular Targeting Agent
9%
Cell Viability
9%
Glycol
9%
Binding Site
9%
Metabolic
9%
Antigen
9%
Calcium(0)
8%
Hydrocarbon
8%
Phosphotransferase Inhibitor
8%
Molecule
8%
Pharmacological Metabolism
8%
Shikonin
8%
Oxidative Stress
8%
Modification
8%
Marker
8%
Chemistry
8%
Protective
8%
Lipopolysaccharide
8%
Application
7%
Flavonoid
7%
Vorinostat
7%
Membrane Potential
7%
Biological Marker
7%
Weight
7%
Total Synthesis
7%
Cleavage
7%
Occurrence in Nature
7%
Anilide
6%
Heat
6%
Flow
6%
Chidamide
6%
Cantharidin
6%
Substitution Reaction
6%
Lipid
6%
Superoxide
6%
Hsp90 Inhibitor
6%
Alkannin
6%
Nanoparticle
6%
Antiinflammatory
5%
Tyrosine
5%
Antimitotic Agent
5%
Poly(ethylene Glycol)
5%
Glucose
5%
Drug Target
5%
Indoline
5%
Plasma
5%
EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor
5%
Proliferative
5%
Genotoxic
5%
Antimitotic
5%
Chemoattractant
5%
Microtubule-Destabilising Agent
5%
Haematological
5%
Benzamide
5%
Clearance
5%
Enzyme Activity
5%